MUMBAI, Sept 29 (Reuters) - India's Sun Pharmaceutical Industries is planning to raise around 100 billion rupees ($1.04 billion) via a upee-denominated debt sale to partly fund a bridge loan it took to acquire US healthcare firm Organon & Co., three sources said on Tuesday.
MUMBAI, Sept 29 (Reuters) - India's Sun Pharmaceutical Industries is planning to raise around 100 billion rupees ($1.04 billion) via a upee-denominated debt sale to partly fund a bridge loan it took to acquire US healthcare firm Organon & Co., three sources said on Tuesday.
<iframe src="https://hindustansphere.com/embed/cluster/1cd2958443eb80d178cd03c4e26bd99075547a0e" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="India's Sun Pharma plans $1 billion local debt sale for loan takeout"></iframe>
